期刊文献+

帕罗西汀联合小剂量奥氮平对轻度抑郁伴失眠患者生命质量的影响 被引量:2

Effect of paroxetine combined with low-dose olanzapine on quality of life in patients with mild depression and insomnia
下载PDF
导出
摘要 目的:探讨对轻度抑郁伴失眠患者应用帕罗西汀联合小剂量的奥氮平治疗的效果。方法:选取2016年2月至2018年12月广州市惠爱医院收治的抑郁伴失眠患者68例作为研究对象,随机分成对照组与观察组,每组34例,对照组为患者单用帕罗西汀治疗,观察组使用帕罗西汀+小剂量奥氮平治疗,观察2组治疗效果。结果:2组患者治疗后汉密尔顿抑郁量表(HAMD)评分均较治疗前降低,匹兹堡睡眠质量指数(PSQI)评分均较治疗前提高,但观察组降低/提高幅度明显大于对照组(P <0. 05);治疗后观察组患者在生理、心理、社会及环境等各个方面的生命质量评分上均显著高于对照组(P <0. 05)。结论:针对轻度抑郁伴失眠的患者,给予患者应用帕罗西汀结合小剂量的奥氮平治疗,可以显著改善患者的抑郁及失眠症状,并可提高患者生命质量,因此值得在临床中大力推广应用。 Objective: To investigate the effect of paroxetine combined with low-dose olanzapine in patients with mild depression and insomnia. Methods: A Total of 68 subjects were randomly divided into experimental group(34 cases)and control group(34 cases).The control group was treated with paroxetine alone.The experimental group was treated with paroxetine + low-dose olanzapine effect. Results: The Hamilton Depression Scale(HAMD)scores of the two groups were lower than those before treatment.The Pittsburgh Sleep Quality Index(PSQI)scores were higher than those before treatment,but the decrease/improvement of the experimental group was significantly greater than that of the control group( P <0.05).After treatment,the patients in the observation group had significantly higher quality of life scores in physical,psychological,social and environmental aspects than the control group( P <0.05). Conclusion: For patients with mild depression and insomnia,the application of paroxetine combined with low-dose olanzapine can significantly improve the symptoms of depression and insomnia,and improve the quality of life of patients,so it is worthy of popularization in clinical practice.
作者 徐健雄 段炼 徐世超 丁毅 Xu Jianxiong;Duan Lian;Xu Shichao;Ding Yi(Guangzhou Huiai Hospital,Guangzhou 510370,China)
出处 《世界睡眠医学杂志》 2019年第3期255-256,共2页 World Journal of Sleep Medicine
关键词 帕罗西汀 小剂量奥氮平 轻度抑郁 失眠 生命质量 Paroxetine Low-dose olanzapine Mild depression Insomnia Quality of life
  • 相关文献

参考文献7

二级参考文献57

  • 1刘贤臣,唐茂芹,胡蕾,王爱祯,吴宏新,赵贵芳,高春霓,李万顺.匹兹堡睡眠质量指数的信度和效度研究[J].中华精神科杂志,1996,29(2):103-107. 被引量:3389
  • 2方建忠,梅其一,杨小男.非典型抗精神病药对难治性抑郁症的治疗作用[J].临床精神医学杂志,2007,17(1):36-37. 被引量:60
  • 3Al-Asadi AM,Klein B,Meyer D.Multiple comorbidities of 21 psychological disorders and relationships with psychosocial variables:a study of the online assessment and diagnostic system within a web-based population[J].J Med Internet Res,2015,17(2):e55.
  • 4Rechtschaffen A,Kales A.A manual of standardized terminology,techniques and scoring system for sleep stages of luman subjects[S].Tokyo:Ishiyalu Publishers,1977:L1-12.
  • 5Nierenberg AA,Keefe BR,Leslie VC,et al.Residual symptoms in depressed patients who respond acutely to fluoxetine[J].J Clin Psychiatry,1999,60(4):221.
  • 6Seppi K,Weintraub D,Coelho M,et al.The movement disorder society evidence-based medicine review update:treatments for the non-motor symptoms of Parkinson's disease[J].Mov Disord,2011,26(Suppl 3):s42.
  • 7Ellis JG,Deary V,Troxel WM.The role of perceived partner alliance on the efficacy of CBT-I:preliminary findings from the Partner Alliance in insomnia research study(PAIRS)[J].Behav Sleep Med,2015,13(1):64.
  • 8Tamayo JM,Sutton VK,Mattei MA,et al.Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression:an open-label,randomized,flexible-dose study in Puerto Rico[J].J Clin Psychopharmacol,2009,29(4):358.
  • 9Yoshimura R,Hori H,Umene-Nakano W,et al.Comparison of lithium,aripiprazole and olanzapine as augmentation to paroxetine for inpatients with major depressive disorder[J].Ther Adv Phychopharmacol,2014,4(3):123.
  • 10COVASSIN N, DE ZAMBOTTI M, SARLO M, et al. Cognitive per- formance and cardiovascular markets of hyperarousal in primary in- somnia [J]. Int J Psychophysiol, 2011 , 80( 1 ) :79 -86.

共引文献86

同被引文献59

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部